maaf email atau password anda salah

Satu Akun, Untuk Semua Akses

Forgot Password ? Click Here

atau Masuk melalui


Belum Memiliki Akun Daftar di Sini

Satu Akun, Untuk Semua Akses

Have an account? Log in here

Konfirmasi Email

Kami telah mengirimkan link aktivasi melalui email ke

Klik link aktivasi dan dapatkan akses membaca 2 artikel gratis non Laput di koran dan Majalah Tempo

Jika Anda tidak menerima email,
Kirimkan Lagi Sekarang

Satu Akun, Untuk Semua Akses

Enter your email, untuk mereset password

Konfirmasi Email

Kami telah mengirimkan link reset password melalui email ke

Ubah No. Telepon

Ubah Password

Topik Favorit

Hapus Berita

Apakah Anda yakin akan menghapus berita?

Ubah Data Diri

Jenis Kelamin

Red-and-White Vaccine Can be Manufactured in 2022

Monday, 9 August 2021

Galvanized by alarming spikes in numbers of positive cases and deaths resulting from the Delta variant of Covid-19, Bio Farma is accelerating the production of Covid-19 vaccines. Yet, vaccine stocks remain stagnant with uneven distribution in many regions. With a production capacity of up to 6 million doses per week or 250 million doses a year, Bio Farma’s CEO Honesti Basyir hopes that the company can fulfill the country’s vaccine need.

Bio Farma CEO Honesti Basyir in Bandung, West Java, August 2. Tempo/Prima Mulia . tempo : 168558337438_

HONESTI Basyir, 53, is racing against time. The government’s target to speed up vaccination in the regions has impelled Bio Farma, the state-owned pharmaceutical company Honesti leads, to beef up Sinovac vaccine production capacity to its maximum, which is 250 million doses annually. “At the same time, we are also adding production capacity for (state-promoted) vaccine or Merah Putih (Red-and-White) vaccine,” said the Chief Exec


Subscribe to continue reading.
We craft news with stories.

For the benefits of subscribing to Digital Tempo, See More

The Best Choice

Rp 54.945/Month

Active for 12 Months, Rp 659.340

  • *You Save -Rp 102.000
  • *Guaranteed update of up to 52 Editions of Tempo Magazine

Rp 64.380/Month

Active Every Month Cancel Anytime

  • *Free for the first month if using a Credit Card

See Other Packages

Already a Subscribed? Log in here
To receive daily news by Email, Sign up for Tempo ID.


Get daily summary of exclusive and in-depth news in your email Inbox by joining the Newsletter

More Articles

More exclusive contents

  • May 29, 2023

  • May 22, 2023

  • May 15, 2023

  • May 8, 2023

Independent journalism needs public support. By subscribing to Tempo, you will contribute to our ongoing efforts to produce accurate, in-depth and reliable information. We believe that you and everyone else can make all the right decisions if you receive correct and complete information. For this reason, since its establishment on March 6, 1971, Tempo has been and will always be committed to hard-hitting investigative journalism. For the public and the Republic.

Login Subscribe